Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzia Varettoni

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Factors predicting transformation of asymptomatic IgM monoclonal gammopathyAntonino Greco, Alessandra Tedeschi, Marzia Varettoni, et al.
Hematological Oncology|September 8, 2018
Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemiaAlessandra Tedeschi, Concetta Conticello, Rita Rizzi, et al.
European Journal of Haematology|June 13, 2009
Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-livedAlessandro Corso, Marzia Varettoni, Silvia Mangiacavalli, et al.
Clinical Lymphoma|March 30, 2005
Clinical characteristics and outcome of immunoglobulin M-related disordersClara Cesana, Luciana Barbarano, Sara Miqueleiz, et al.
Clinical Lymphoma|March 30, 2005
Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathiesEnrica Morra, Clara Cesana, Catherine Klersy, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2006
Changes in multiple myeloma epidemiology in the last thirty years: a single centre experiencePatrizia Zappasodi, Alessandro Corso, Catherine Klersy, et al.
Seminars in Oncology|April 30, 2003
Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathyEnrica Morra, Clara Cesana, Catherine Klersy, et al.
Cancer|May 17, 2005
Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effectAlessandro Corso, Eleonora Ferretti, Monia Lunghi, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 28, 2013
Associated cancers in Waldenström macroglobulinemia: clues for common genetic predispositionEnrica Morra, Marzia Varettoni, Alessandra Tedeschi, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2013
Microarray demonstrates different gene expression profiling signatures between Waldenström macroglobulinemia and IgM monoclonal gammopathy of undetermined significanceAlessandra Trojani, Antonino Greco, Alessandra Tedeschi, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Factors predicting transformation of asymptomatic IgM monoclonal gammopathyAntonino Greco, Alessandra Tedeschi, Marzia Varettoni, et al.
Hematological Oncology|September 8, 2018
Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemiaAlessandra Tedeschi, Concetta Conticello, Rita Rizzi, et al.
European Journal of Haematology|June 13, 2009
Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-livedAlessandro Corso, Marzia Varettoni, Silvia Mangiacavalli, et al.
Clinical Lymphoma|March 30, 2005
Clinical characteristics and outcome of immunoglobulin M-related disordersClara Cesana, Luciana Barbarano, Sara Miqueleiz, et al.
Clinical Lymphoma|March 30, 2005
Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathiesEnrica Morra, Clara Cesana, Catherine Klersy, et al.
European Journal of Cancer (Oxford, England : 1990)|January 13, 2006
Changes in multiple myeloma epidemiology in the last thirty years: a single centre experiencePatrizia Zappasodi, Alessandro Corso, Catherine Klersy, et al.
Seminars in Oncology|April 30, 2003
Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathyEnrica Morra, Clara Cesana, Catherine Klersy, et al.
Cancer|May 17, 2005
Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effectAlessandro Corso, Eleonora Ferretti, Monia Lunghi, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 28, 2013
Associated cancers in Waldenström macroglobulinemia: clues for common genetic predispositionEnrica Morra, Marzia Varettoni, Alessandra Tedeschi, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2013
Microarray demonstrates different gene expression profiling signatures between Waldenström macroglobulinemia and IgM monoclonal gammopathy of undetermined significanceAlessandra Trojani, Antonino Greco, Alessandra Tedeschi, et al.
Pageof 10